Our Grant
Sab’s research group focuses on the three interrelated receptor proteins that are the predominant mediators of smooth muscle contractility in male genitourinary tissues. Through an MCI Seed Grant, they are working on developing inhibitors of a target that causes the vas deferens to contract. By preventing this contraction, sperm are unable to move from their normal storage site in the cauda epididymis through the genitourinary tissue to the base of the urethra, where they are normally ejaculated from the body.
This novel approach to contraception leaves sperm development and sexual health unimpacted, and the nature of the target indicates that the male contraceptive can be potentially orally administered and would be readily reversible.
Blog Posts
A Conversation with MCI Grantee Dr. Sab Ventura
Media
Sab Ventura on the Australian Broadcasting Corp, Jun 2020
MCI Grantee Sab Ventura on The Byron Cooke Show, Nov 2020